Reversibility of mitochondrial toxicity in HIV lipoatrophy

Trial Profile

Reversibility of mitochondrial toxicity in HIV lipoatrophy

Phase of Trial: Phase II

Latest Information Update: 17 May 2017

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals; Stavudine; Zidovudine
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Mar 2010 Actual end date (Oct 2008) added as reported by
    • 02 Mar 2010 Status changed from recruiting to completed as reported by
    • 08 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top